Skip to main content

Peer Review reports

From: Changes in fibroblast growth factor 23 levels in normophosphatemic patients with chronic kidney disease stage 3 treated with lanthanum carbonate: results of the PREFECT study, a phase 2a, double blind, randomized, placebo-controlled trial

Original Submission
15 Nov 2013 Submitted Original manuscript
13 Feb 2014 Author responded Author comments - Pablo Antonio Urena Torres
4 Dec 2013 Reviewed Reviewer Report - Bjorn Meijers
7 Dec 2013 Reviewed Reviewer Report - Carmine Zoccali
18 Dec 2013 Reviewed Reviewer Report - Jessica Kendrick
Resubmission - Version 2
13 Feb 2014 Submitted Manuscript version 2
15 Feb 2014 Author responded Author comments - Pablo Antonio Urena Torres
Resubmission - Version 3
15 Feb 2014 Submitted Manuscript version 3
24 Mar 2014 Author responded Author comments - Pablo Antonio Urena Torres
4 Mar 2014 Reviewed Reviewer Report - Bjorn Meijers
2 Mar 2014 Reviewed Reviewer Report - Carmine Zoccali
8 Mar 2014 Reviewed Reviewer Report - Jessica Kendrick
Resubmission - Version 4
24 Mar 2014 Submitted Manuscript version 4
14 Apr 2014 Author responded Author comments - Pablo Antonio Urena Torres
Resubmission - Version 5
14 Apr 2014 Submitted Manuscript version 5
Publishing
24 Apr 2014 Editorially accepted
5 May 2014 Article published 10.1186/1471-2369-15-71

You can find further information about peer review here.

Back to article page
\